DCPH Chart
- 52-Week Range: $6.87 - $38.16
- Market Capitalization: $722.42M
- Short Percentage: 0%
- Target Price: $10.78
- Shares Outstanding: 66.22M
- Next Earnings: Feb 8
Catalysts
CategoryCatalyst
Earnings
DCPH released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial ResultsBusiness Wire | May 4th
- Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR Annual MeetingBusiness Wire | April 12th
- Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare ConferenceBusiness Wire | March 9th
- Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 8th
- Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial ResultsBusiness Wire | February 8th
- Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor ConferencesBusiness Wire | February 2nd
- Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire | January 3rd
- Deciphera Pharmaceuticals Is Trying to Beat Financial Cancer — And Losing HardInvestorPlace | November 30th
Company Info
Website: https://www.deciphera.com
Address: 200 Smith Street, Waltham, MA, United States, 02451
Sector: Healthcare
Industry: Biotechnology
Full time employees: 280
Address: 200 Smith Street, Waltham, MA, United States, 02451
Sector: Healthcare
Industry: Biotechnology
Full time employees: 280
$DCPH we want higher!!!
$DCPH death cross will complete today
$DCPH still bullish
$DCPH oversold
$DCPH prepare your cash to buy dip
$DCPH take what we can get
$DCPH whats the news????
$DCPH here to raid
$DCPH has just been halted from trading.
$DCPH do what the markets tells you to do not the other way around